Christopher Ballas

Mimecast Google Cloud Hosting Outlook Microsoft Office 365 Amazon AWS WordPress.org Google Tag Manager Mobile Friendly Nginx IoT Remote Micro

gene therapy rare disease clinical research drug development dermatology epidermolysis bullosa life sciences personalized medicine biotechnology genetics orphan drug pediatric disease bioscience biotechnology research cell therapy autologous fibroblast technology dystrophic epidermolysis bullosa deb genetic diseases biological therapies monogenic disorders clinical trials fda orphan drug designation rare diseases ex vivo technology regenerative medicine cgmp manufacturing wound healing collagen vii genetically modified fibroblasts local injections chronic wounds therapeutic pipeline genetic skin disorders collagen therapy investigational therapies patient-specific treatments biological product disease-modifying therapies clinical study patient-derived cells genetic correction skin integrity patient-centric solutions cell-based therapy customized treatments advanced therapy tissue engineering regulatory approvals health innovation scientific research collaborative healthcare patient outcomes biopharmaceuticals therapeutic approaches clinical development health care health wellness & fitness hospital & health care